M I Mackness|P N Durrington - JoVE Visualize

Showing results (11-20 of 161) with videos related to

Pageof 17

Sort By:

The Biochemical Journal|September 15, 1993

The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidationM I Mackness, C Abbott, S Arrol, et al.

Biochimica Et Biophysica Acta|October 15, 1991

Lipoprotein secretion by the human hepatoma cell line Hep G2: differential rates of accumulation of apolipoprotein B and lipoprotein lipids in tissue culture media in response to albumin, glucose and oleateS Arrol, M I Mackness, I Laing, et al.

Atherosclerosis|December 1, 1993

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonaseM I Mackness, S Arrol, C Abbott, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1997

Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosisB Mackness, R Hunt, P N Durrington, et al.

Atherosclerosis|October 1, 1993

The immediate effect of streptokinase on serum lipoprotein(a) concentration and the effect of myocardial infarction on serum lipoprotein(a), apolipoproteins A1 and B, lipids and C-reactive proteinA D MBewu, P N Durrington, S Bulleid, et al.

Chemico-Biological Interactions|June 1, 1993

Is paraoxonase related to atherosclerosisM I Mackness, S Arrol, C A Abbott, et al.

Atherosclerosis|January 6, 1995

Spontaneous platelet aggregation in whole blood is increased in non-insulin-dependent diabetes mellitus and in female but not male patients with primary dyslipidemiaV C Menys, D Bhatnagar, M I Mackness, et al.

Diabetic Medicine : a Journal of the British Diabetic Association|May 26, 1999

Susceptibility of low- and high-density lipoproteins from diabetic subjects to in vitro oxidative modificationK Julier, M I Mackness, J D Dean, et al.

British Journal of Pharmacology|October 6, 1997

Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxonB Mackness, M I Mackness, S Arrol, et al.

FEBS Letters|March 20, 1998

Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modificationB Mackness, M I Mackness, S Arrol, et al.

Pageof 17

Showing results (11-20 of 161) with videos related to

Sort By:

Pageof 17

The Biochemical Journal|September 15, 1993

The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidationM I Mackness, C Abbott, S Arrol, et al.

Biochimica Et Biophysica Acta|October 15, 1991

Lipoprotein secretion by the human hepatoma cell line Hep G2: differential rates of accumulation of apolipoprotein B and lipoprotein lipids in tissue culture media in response to albumin, glucose and oleateS Arrol, M I Mackness, I Laing, et al.

Atherosclerosis|December 1, 1993

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonaseM I Mackness, S Arrol, C Abbott, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1997

Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosisB Mackness, R Hunt, P N Durrington, et al.

Atherosclerosis|October 1, 1993

The immediate effect of streptokinase on serum lipoprotein(a) concentration and the effect of myocardial infarction on serum lipoprotein(a), apolipoproteins A1 and B, lipids and C-reactive proteinA D MBewu, P N Durrington, S Bulleid, et al.

Chemico-Biological Interactions|June 1, 1993

Is paraoxonase related to atherosclerosisM I Mackness, S Arrol, C A Abbott, et al.

Atherosclerosis|January 6, 1995

Spontaneous platelet aggregation in whole blood is increased in non-insulin-dependent diabetes mellitus and in female but not male patients with primary dyslipidemiaV C Menys, D Bhatnagar, M I Mackness, et al.

Diabetic Medicine : a Journal of the British Diabetic Association|May 26, 1999

Susceptibility of low- and high-density lipoproteins from diabetic subjects to in vitro oxidative modificationK Julier, M I Mackness, J D Dean, et al.

British Journal of Pharmacology|October 6, 1997

Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxonB Mackness, M I Mackness, S Arrol, et al.

FEBS Letters|March 20, 1998

Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modificationB Mackness, M I Mackness, S Arrol, et al.

Pageof 17